Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there. Did your doctor somehow miss the recovery protocol that Pedro Bach-y-Rita used to recover fully back in 1958 with only a partial brain?

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Saturday, January 2, 2016

Computerized Cognitive Rehabilitation of Attention and Executive Function in Acquired Brain Injury: A Systematic Review

Since your doctor is obviously rigorously following all stroke research s/he does not need this review on cognition. But in case s/he doesn't then you could train them on the finer points. Your doctor is really good if they are keeping up with 4931 articles. Send your doctor after what the computerized rehabilitation protocols are. 

Computerized Cognitive Rehabilitation of Attention and Executive Function in Acquired Brain Injury: A Systematic Review



VA Boston Healthcare System, Psychology Research Service (Dr Bogdanova and Mss Yee and Ho); and Department of Psychiatry, Boston University School of Medicine (Dr Bogdanova and Ms Ho), and Boston University School of Public Health (Ms Yee), Boston, Massachusetts; Department of Neuropsychology, JFK-Johnson Rehabilitation Institute, Edison, New Jersey (Dr Cicerone); and Department of Physical Medicine and Rehabilitation, Rutgers Robert Wood Johnson Medical School, Edison, New Jersey (Dr Cicerone).
Highlight Terms
Comprehensive review of the use of computerized treatment as a rehabilitation tool for attention and executive function in adults (aged 18 years or older) who suffered an acquired brain injury.Systematic review of empirical research.Two reviewers independently assessed articles using the methodological quality criteria of Cicerone et al. Data extracted included sample size, diagnosis, intervention information, treatment schedule, assessment methods, and outcome measures.A literature review (PubMed, EMBASE, Ovid, Cochrane, PsychINFO, CINAHL) generated a total of 4931 publications. Twenty-eight studies using computerized cognitive interventions targeting attention and executive functions were included in this review. In 23 studies, significant improvements in attention and executive function subsequent to training were reported; in the remaining 5, promising trends were observed.Preliminary evidence suggests improvements in cognitive function following computerized rehabilitation for acquired brain injury populations including traumatic brain injury and stroke. Further studies are needed to address methodological issues (eg, small sample size, inadequate control groups) and to inform development of guidelines and standardized protocols.

Robert Waldinger: What makes a good life? Lessons from the longest study on happiness

It's all about relationships. If I were to look back at when I was 50 the betting would be that I won't be healthy at 80. Of course it took having a stroke to kick me out of my relationship and find happiness with friends.
http://www.ted.com/talks/robert_waldinger_what_makes_a_good_life_lessons_from_the_longest_study_on_happiness/transcript?language=en
Part of the transcript:
Once we had followed our men all the way into their 80s, we wanted to look back at them at midlife and to see if we could predict who was going to grow into a happy, healthy octogenarian and who wasn't. And when we gathered together everything we knew about them at age 50, it wasn't their middle age cholesterol levels that predicted how they were going to grow old. It was how satisfied they were in their relationships. The people who were the most satisfied in their relationships at age 50 were the healthiest at age 80. And good, close relationships seem to buffer us from some of the slings and arrows of getting old. Our most happily partnered men and women reported, in their 80s, that on the days when they had more physical pain, their mood stayed just as happy. But the people who were in unhappy relationships, on the days when they reported more physical pain, it was magnified by more emotional pain.
09:03 And the third big lesson that we learned about relationships and our health is that good relationships don't just protect our bodies, they protect our brains. It turns out that being in a securely attached relationship to another person in your 80s is protective, that the people who are in relationships where they really feel they can count on the other person in times of need, those people's memories stay sharper longer. And the people in relationships where they feel they really can't count on the other one, those are the people who experience earlier memory decline. And those good relationships, they don't have to be smooth all the time. Some of our octogenarian couples could bicker with each other day in and day out, but as long as they felt that they could really count on the other when the going got tough, those arguments didn't take a toll on their memories.
10:00 So this message, that good, close relationships are good for our health and well-being, this is wisdom that's as old as the hills. Why is this so hard to get and so easy to ignore? Well, we're human. What we'd really like is a quick fix, something we can get that'll make our lives good and keep them that way. Relationships are messy and they're complicated and the hard work of tending to family and friends, it's not sexy or glamorous. It's also lifelong. It never ends. The people in our 75-year study who were the happiest in retirement were the people who had actively worked to replace workmates with new playmates. Just like the millennials in that recent survey, many of our men when they were starting out as young adults really believed that fame and wealth and high achievement were what they needed to go after to have a good life. But over and over, over these 75 years, our study has shown that the people who fared the best were the people who leaned in to relationships, with family, with friends, with community.

Prevention of cardiovascular events with antiplatelet treatment: does time of intake matter for aspirin and ADP receptor blockers?

Do you even have a time protocol for your medicine? How long before your doctor changes that based on this research? Never? Do not make changes on your own.
http://www.ncbi.nlm.nih.gov/pubmed/26334227

Abstract

Long-term evidence supports a clustering of cardiovascular events in the early morning. Several studies have shown that platelet hyper-reactivity to various stimuli is also present at this period of the day. However, the idea of treatment strategies reflecting the circadian variation in platelet reactivity has been largely neglected so far, and this is true despite the huge number of patients being treated with these drugs. Some pharmacodynamic data suggest that early-morning platelet hyper-reactivity may be overcome by shifting aspirin intake to the bedtime. However, there is lack of evidence whether shifting the time of intake or splitting the daily dose of P2Y12-inhibitors with a regular QD dosing (clopidogrel or prasugrel) to the evening would be effective to overcome platelet hyper-reactivity or to suppress the excess of cardiovascular events observed during morning hours. Further research is warranted to clarify whether such a simple and costless effort like dose shifting or splitting may be beneficial to prevent cardiovascular events.

KEYWORDS:

ADP receptors; antiplatelet agents; antiplatelet drugs; clinical trials; platelet pharmacology
PMID:
26334227
[PubMed - in process]

Discharge home after acute stroke: Differences between older and younger patients

Completely and totally the wrong conclusion. The solution you would have to propose is that before your stroke you get a caring and loving spouse. The goal should be 100% return to home. You haven't even identified the problem. The problem is that stroke rehab is a total fucking failure. You solve that by not having to provide very much of it. And that is by researching and creating protocols that stop the neuronal cascade of death in the first week.
http://www.ncbi.nlm.nih.gov/pubmed/26667264

Abstract

OBJECTIVE:

To identify determinants for discharge destination of older (≥ 70 years) and younger (< 70 years) acute stroke patients.

DESIGN:

Multicentre prospective cohort.

PATIENTS:

A total of 395 patients, within 7 days of clinically evaluated stroke, were included from 6 hospital stroke units.

METHODS:

The main outcome measure was discharge destination (home vs clinical rehabilitation). Independent variables were: demographic factors, stroke characteristics, functional impairments and disabilities, cognition, comorbidity, and premorbid social participation. Multivariate logistic regression analysis established the independent strength of the contribution of possible determinants to discharge destination.

RESULTS:

Seventy-six percent of younger patients were discharged home, compared with 63% of older patients. Most of the younger patients discharged to clinical rehabilitation (71%) had a spouse, whereas only 40% of the older age group discharged to clinical rehabilitation had a spouse. Multivariate analysis showed that, besides National Institutes of Health Stroke Scale and Barthel Index scores, having a spouse was an important determinant for discharge home in the older age group (adjusted odds ratio 4.77, 95% confidence interval 2.01-11.31), but not in the younger age group.

CONCLUSION:

The presence of a spouse is an additional important factor determining discharge home in older stroke patients. It is important to monitor and support informal caregivers in order to provide appropriate care for older community-dwelling stroke patients.
PMID:
26667264
[PubMed - as supplied by publisher]

Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects

I'm sure your doctor will never prescribe anything like this to you even though it does promote neurogenesis.

Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects

Your doctor can get some here:

Cannabis Oil (Cannabidiol CBD) without a prescription in all 50 United States.

Remember, do nothing without your doctors prescription.

 

Friday, January 1, 2016

Augmenting NMDA receptor signaling boosts experience-dependent neuroplasticity in the adult human brain

You'll have to ask your doctor how much this boosts neuroplasticity and how they are going to test d-cycloserine (DCS) in a stroke protocol to prove it works. When is it going to be available in their clinic?
  1. Robert F. Asarnowa,e,1
  1. Edited by Karin Foerde, New York University, New York, NY, and accepted by the Editorial Board October 28, 2015 (received for review May 12, 2015)

Significance

Experience-dependent plasticity is the capacity of the brain to undergo changes following environmental input and use, and is a primary means through which the adult brain enables new behavior. In the current study, we provide evidence that enhancing signaling at the glutamate N-methyl-d-aspartate receptor (NMDAR) can enhance the mechanism underlying many forms of experience-dependent plasticity (i.e., long-term potentiation of synaptic currents) and also enhance experience-dependent learning in healthy adult humans. This suggests exciting possibilities for manipulating plasticity in adults and has implications for treating neurological and neuropsychiatric disorders in which experience-dependent plasticity is impaired.

Abstract

Experience-dependent plasticity is a fundamental property of the brain. It is critical for everyday function, is impaired in a range of neurological and psychiatric disorders, and frequently depends on long-term potentiation (LTP). Preclinical studies suggest that augmenting N-methyl-d-aspartate receptor (NMDAR) signaling may promote experience-dependent plasticity; however, a lack of noninvasive methods has limited our ability to test this idea in humans until recently. We examined the effects of enhancing NMDAR signaling using d-cycloserine (DCS) on a recently developed LTP EEG paradigm that uses high-frequency visual stimulation (HFvS) to induce neural potentiation in visual cortex neurons, as well as on three cognitive tasks: a weather prediction task (WPT), an information integration task (IIT), and a n-back task. The WPT and IIT are learning tasks that require practice with feedback to reach optimal performance. The n-back assesses working memory. Healthy adults were randomized to receive DCS (100 mg; n = 32) or placebo (n = 33); groups were similar in IQ and demographic characteristics. Participants who received DCS showed enhanced potentiation of neural responses following repetitive HFvS, as well as enhanced performance on the WPT and IIT. Groups did not differ on the n-back. Augmenting NMDAR signaling using DCS therefore enhanced activity-dependent plasticity in human adults, as demonstrated by lasting enhancement of neural potentiation following repetitive HFvS and accelerated acquisition of two learning tasks. Results highlight the utility of considering cellular mechanisms underlying distinct cognitive functions when investigating potential cognitive enhancers.
o get
http://www.pnas.org/content/112/50/15331.abstract
  1. Robert F. Asarnowa,e,1
  1. Edited by Karin Foerde, New York University, New York, NY, and accepted by the Editorial Board October 28, 2015 (received for review May 12, 2015)

Significance

Experience-dependent plasticity is the capacity of the brain to undergo changes following environmental input and use, and is a primary means through which the adult brain enables new behavior. In the current study, we provide evidence that enhancing signaling at the glutamate N-methyl-d-aspartate receptor (NMDAR) can enhance the mechanism underlying many forms of experience-dependent plasticity (i.e., long-term potentiation of synaptic currents) and also enhance experience-dependent learning in healthy adult humans. This suggests exciting possibilities for manipulating plasticity in adults and has implications for treating neurological and neuropsychiatric disorders in which experience-dependent plasticity is impaired.

Abstract

Experience-dependent plasticity is a fundamental property of the brain. It is critical for everyday function, is impaired in a range of neurological and psychiatric disorders, and frequently depends on long-term potentiation (LTP). Preclinical studies suggest that augmenting N-methyl-d-aspartate receptor (NMDAR) signaling may promote experience-dependent plasticity; however, a lack of noninvasive methods has limited our ability to test this idea in humans until recently. We examined the effects of enhancing NMDAR signaling using d-cycloserine (DCS) on a recently developed LTP EEG paradigm that uses high-frequency visual stimulation (HFvS) to induce neural potentiation in visual cortex neurons, as well as on three cognitive tasks: a weather prediction task (WPT), an information integration task (IIT), and a n-back task. The WPT and IIT are learning tasks that require practice with feedback to reach optimal performance. The n-back assesses working memory. Healthy adults were randomized to receive DCS (100 mg; n = 32) or placebo (n = 33); groups were similar in IQ and demographic characteristics. Participants who received DCS showed enhanced potentiation of neural responses following repetitive HFvS, as well as enhanced performance on the WPT and IIT. Groups did not differ on the n-back. Augmenting NMDAR signaling using DCS therefore enhanced activity-dependent plasticity in human adults, as demonstrated by lasting enhancement of neural potentiation following repetitive HFvS and accelerated acquisition of two learning tasks. Results highlight the utility of considering cellular mechanisms underlying distinct cognitive functions when investigating potential cognitive enhancers.

Positron Emission Tomographic Imaging in Stroke Cross-Sectional and Follow-Up Assessment of Amyloid in Ischemic Stroke

So if there was β-amyloid accumulation in the stroke area what difference would it make if that area is dead? Or were they trying to say it was located in the penumbra? If this didn't find anything why exactly is there an increased risk of dementia/Alzheimers after a stroke?
http://stroke.ahajournals.org/content/47/1/113.full?
  1. Amy Brodtmann, PhD*
+ Author Affiliations
  1. From the Florey Institute of Neuroscience and Mental Health, Melbourne, Victoria, Australia (R.S., T.L., L.C., J.V.L., G.D., A.D.); University of Melbourne, Victoria, Australia (R.S., V.L.V., L.C., J.V.L., C.R., G.D., A.D.); Universiti Kebangsaan Malaysia Medical Centre, Bangi, Malaysia (R.S.); Gothenburg University, Gothenburg, Sweden (T.L.); and Austin Hospital PET Centre, Melbourne, Victoria, Australia (V.L.V., C.R.).
  1. Correspondence to Amy Brodtmann, PhD, Florey Institute of Neuroscience and Mental Health, Melbourne Brain Centre, 245 Burgundy St, Heidelberg, Victoria 3081, Australia. E-mail agbrod@unimelb.edu.au
  1. ↵* Drs Donnan and Brodtmann contributed equally.

Abstract

Background and Purpose—Cardiovascular risk factors significantly increase the risk of developing Alzheimer disease. A possible mechanism may be via ischemic infarction–driving amyloid deposition. We conducted a study to determine the presence of β-amyloid in infarct, peri-infarct, and hemispheric areas after stroke. We hypothesized that an infarct would trigger β-amyloid deposition, with deposition over time.
Methods—Patients were recruited within 40 days of acute ischemic stroke and imaged with computed tomographic or magnetic resonance imaging and Pittsburgh compound B (11C-PiB) positron emission tomographic scans. Follow-up positron emission tomographic scanning was performed in a subgroup ≤18 months after the stroke event. Standardized uptake value ratios for regions of interest were analyzed after coregistration.
Results—Forty-seven patients were imaged with 11C-PiB positron emission tomography. There was an increase in 11C-PiB accumulation in the stroke area compared with a reference region in the contralesional hemisphere, which was not statistically significant (median difference in standardized uptake value ratio, 0.07 [95% confidence interval, −0.06 to 0.123]; P=0.452). There was no significant increase in the accumulation of 11C-PiB in the peri-infarct region or in the ipsilesional hemisphere (median difference in standardized uptake value ratio, 0.04 [95% confidence interval, −0.02 to 0.10]; P=0.095). We repeated 11C-PiB positron emission tomography in 21 patients and found a significant reduction in accumulation of 11C-PiB between regions of interest (median difference in standardized uptake value ratio, −0.08 [95% confidence interval, −0.23 to −0.03]; P=0.04).
Conclusions—There was no significant increase in 11C-PiB accumulation in or around the infarct. There was no increase in ipsilesional hemispheric 11C-PiB accumulation over time. We found no evidence that infarction leads to sustained or increased β-amyloid deposition ≤18 months after stroke.

PowerDot Wearable Sport Muscle Stimulator

No idea if this would help us or not, so ask your therapist. A bit pricey at $129.99 or 249.99 for two.
https://www.touchofmodern.com/sales/powerdot-dcb34f8c-6593-4a65-a050-a26ff533a120?open=1&utm_source=responsys&utm_medium=email&utm_content=afternoon_email
PowerDot is the solution for any active athlete looking for new ways to work out and recover muscle mass. No matter which active sport you're involved in and whether you’re a busy amateur or a world-record holder, PowerDot can help you improve your sports performance and results. Whether it’s age, genetics or simply lack of time, your muscles can only do so much. With PowerDot, you can give your muscles that extra boost to recover faster and deliver better results for the same effort.

Researchers study neurology of balancing on two legs

If we still do not understand walking then how the hell are our therapists supposed to create a stroke walking protocol to correct our problems in walking? I'm a great example, spasticity that turns my left foot out slightly creates pain in my left foot in various spots and since there is no cure for spasticity, I'm completely screwed.
http://medicalxpress.com/news/2015-12-neurology-legs.html
Walking on two legs is inherently unstable, meaning that the human central nervous system must work hard to maintain balance. Walking motion is maintained by two control approaches—feedforward control, in which the body anticipates possible disturbances to steady walking, and feedback control, when the body reacts to an unseen disturbance to stay upright. The precise mechanisms underlying these control approaches are not yet fully understood.
To uncover variables underpinning , Tetsuro Funato at the University of Electro-Communications, Tokyo, Japan, together with scientists from Kyoto University, used a technique based on 'uncontrolled manifold analysis' (UCM) —a way of quantifying the behavior of different multi-segmental motion, how their relationships are formed and how they are used in response to disturbances.
Funato and his team gathered data from 11 healthy male participants who were asked to walk steadily on a treadmill. The researchers sped up or slowed down the treadmill abruptly, with consecutive disturbances occurring either frequently (within one cycle) or gradually (over a few steps).
The team were interested in the significance of 'intersegmental co-ordination' on walking control - specifically, the interaction of the thigh, shank and foot during motion phases. They compared this with fluctuations in the participants' center of mass, head and limb axis during both steady and disturbed walking.
Their UCM-based results indicated that fluctuations in intersegmental co-ordination were smaller than center of mass, head and limb axis fluctuations. This suggests intersegmental co-ordination may play a significant role in a feedback control of walking by maintaining a continuous cyclic pattern regardless of disturbances.
More information: Tetsuro Funato et al. Validating the feedback control of intersegmental coordination by fluctuation analysis of disturbed walking, Experimental Brain Research (2015). DOI: 10.1007/s00221-015-4216-x

Provided by: University of Electro Communications search and more info website

Single photon emission computed tomography imaging of cerebral blood flow, blood–brain barrier disruption, and apoptosis time course after focal cerebral ischemia in rats

By following up on this in humans we should be able to calculate the numbers of neurons dying during the neuronal cascade of death in the first week. We already know that 1.9 million die per minute during the actual stroke, which leads to the mantra, 'Time is Brain'. We've known this for ten years and yet our fucking failures of stroke associations have done nothing in those ten years to solve anything in stroke. How many gazillions of dead neurons are our stroke associations responsible for killing?  If we can come up with the number dying the first week we might have a chance of actually getting researchers to solve the problem of stopping the 5 causes of neuronal death. But since we have NO stroke strategy or stroke leadership in any part of stroke no will even attempt to solve this. Your children and grandchildren are fucking screwed if they have a stroke since nothing will be done better than today.
http://wso.sagepub.com/content/11/1/117.abstract?
  1. Philippe Garrigue1,2,3
  2. Laura Giacomino4
  3. Chiara Bucci5
  4. Valeria Muzio5
  5. Maria A Filannino5
  6. Florence Sabatier1,6
  7. Françoise Dignat-George1,7
  8. Pascale Pisano1,8
  9. Benjamin Guillet1,2,3⇑
  1. 1INSERM, INSERM UMR_S1076 VRCM Aix-Marseille Université, France
  2. 2APHM, Hôpital La Timone, Service de Radiopharmacie, Marseille, France
  3. 3CERIMED, Aix-Marseille Université, Marseille, France
  4. 4Département Anesthésie-Réanimation adulte, APHM, Aix-Marseille Université, Marseille, France
  5. 5Advanced Accelerator Applications, Colleretto Giacosa (TO), Italy
  6. 6APHM, Laboratoire de Culture et Thérapie Cellulaire, INSERM, Hôpital La Conception, Marseille, France
  7. 7APHM, Hôpital La Conception, Service d’Hématologie, Marseille, France
  8. 8APHM, Pôle Pharmacie, Marseille, France
  1. Benjamin Guillet, Faculté de Pharmacie, 27 Bd Jean Moulin, 13005 Marseille, France. Email: benjamin.guillet@univ-amu.fr

Abstract

Background Cerebral ischemia is a leading cause of disability worldwide and no other effective therapy has been validated to date than intravenous thrombolysis. In this context, many preclinical models have been developed and recent advances in preclinical imaging represent promising tools. Thus, we proposed here to characterize in vivo time profiles of cerebral blood flow, blood–brain barrier disruption and apoptosis following a transient middle cerebral artery occlusion in rats using SPECT/CT imaging.
Methods Rats underwent a 1-h middle cerebral artery occlusion followed by reperfusion. Cerebral blood flow, blood–brain barrier disruption and apoptosis were evaluated by SPECT/CT imaging using respectively 99mTc-HMPAO, 99mTc-DTPA and the experimental 99mTc-Annexin V-128, up to 14 days after middle cerebral artery occlusion. Histological evaluation of apoptosis has been performed using TUNEL method to validate the 99mTc-Annexin V-128 uptake.
Results 99mTc-HMPAO cerebral blood flow evaluation showed hypoperfusion during occlusion, partially restored on days 4 and 7 and sustained up to 14 days after middle cerebral artery occlusion. 99mTc-DTPA SPECT/CT showed a blood–brain barrier disruption starting on day 1 post-middle cerebral artery occlusion, peaking on day 2, with barrier integrity totally restored on day 7. 99mTc-Annexin V-128 SPECT/CT imaging showed significant positive correlation with TUNEL immunohistochemistry and allowed ischemic-induced apoptosis to be detected from day 2 to day 7, peaking on day 3 after middle cerebral artery occlusion.
Conclusions Using SPECT/CT imaging, we showed that after transient middle cerebral artery occlusion in rat there was a sustained decrease in cerebral blood flow followed by blood–brain barrier disruption preceding meanwhile apoptosis. Rodent SPECT/CT imaging of cerebral blood flow, blood–brain barrier disruption and apoptosis appears to be an efficient tool for evaluating neuroprotective drugs and regenerative therapies against cerebral ischemia and time-windows for therapeutic intervention.

MicroTransponder developing neurostimulation technology to allow tinnitus and stroke victims to re-train their brains

Hell, vagus nerve stimulation for stroke has been known for a long time.
Earlier research on this is here July, 2012;
Nerve stimulation plus standard therapy may accelerate stroke recovery
and here Jan. 2013;
UK docs aim to `rewire` brains of stroke patients
and here - Sept. 2013;
Researchers Find Early Success in New Treatment for Stroke Recovery 

And just when the hell will the research be enough to create a stroke protocol?I bet this will still take 50 years to get rolled out because we have no stroke leadership making sure stroke medical teams are using the latest interventions. Remember you can't even suggest this to your doctor because that would be practicing medicine without a license. Whereas your doctor is probably practicing no medicine for stroke at all and has a license. Ask how your doctor will get you to 100% recovery.
http://medcitynews.com/2015/12/microtransponder-developing-neurostimulation-technology-to-treat-tinnitus-and-stroke-victims/?utm_source=MedCity+News+Subscribers&utm_campaign=0c3fc8bac8-MCN+Daily+Email&utm_medium=email&utm_term=0_5092836c41-0c3fc8bac8-408818725

MicroTransponder
Dallas-based MicroTransponder is looking to treat neurological conditions with its aired Vagus Nerve Stimulation, which is designed to help patients with tinnitus as well as stroke victims. The company, which has completed clinical studies, recently announced a $5.5 million round of funding (planned to be used to launch the product in Europe) and now have a paper published in the journal Stroke.
For the treatment of tinnitus, chronic ringing in the ears, they have developed what they call the Serenity System. For stroke victims who have upper limb mobility issues, they have created the Vivistim System.
In an interview, CEO Frank McEachern shared about the recent financing and what MicroTransponder is focused on with its technology:
Can you explain how the MicroTransponder technology actually works?
The Vagus Nerve Stimulation is a pacemaker-type device implanted in the chest. A wire reaches the left vagus nerve in the neck. That system implant generates the electrical current that stimulates the vagus nerve. That basic kind of implant has been used for a long time, but for different purposes – to treat epilepsy. It reduces seizures and has been FDA approved.
In terms of what is being implanted, this is something that is not unique, but what’s novel is when we stimulate the vagus nerve, we are taking advantage of the fact that the nerve is part of the learning system. When we stimulate the vagus nerve, it releases some neurotransmitters that makes what happens in the immediate environment important to the brain.

We get a window where we can generate importance to the brain so that we can direct learning. No one has used neurostimulation to direct learning like we have.
Can you elaborate on the issue of tinnitus and how your device really treats this condition?
Tinnitus, ringing in the ear, is not an ear problem. It’s a brain problem. What happens is there is an abnormal circuit in the brain that is hyper-active. In part of the auditory cortex, a bunch of neurons are firing together and it creates a phantom sound. What we do, is we go in and play frequencies outside of the tinnitus frequency and re-normalize that broken circuit.
Although tinnitus is an issue in the brain, originally, the insult occurs in the ear from a loud noise. Right now, it’s the number one disability for someone in the military. What’s happening is there is damage to the cochlea. Each portion of the cochlea will capture a unique feature of frequency. With certain trauma, one part can be damaged. The cochlea matches one-to-one with your auditory cortex, sending input to one part of that cortext – with damage, it doesn’t make that connection and your brain looking for information from neighboring regions.
That’s abornmal, and the result is that a large area of the cortex is communicating between itself, which is faulty. Our device is designed to re-normalize this information transference.
Is there any similarity to shock therapy in how the brain’s system reacts to this?
I wouldn’t compare it to that. Shock therapy disrupts the system, but with this it is focused on the vagus nerve to release these neurotransmitters that make the brain plastic for a temporary period so we can teach it.
Nobody has done this kind of stimulation to direct brain learning. Say you take a drug that affects the same neurotransmitters, it just floods your system which doesn’t allow the brain to make certain events important.
Beyond tinnitus, how does this work for stroke victims?
A person who has had a stroke, they do regular rehab. After a stroke, about four months later, many have recovered upper limb functions, but about half haven’t. It becomes harder to show improvement through other therapies. It’s hard to continue improvement after the first time of growth, you kind of plateau.
With this, each time a patient does a movement, they get a moment of vagus nerve stimulation. It makes the event important. These are basic motions, but the adult brain doesn’t know these functions are important. You need to make new connections, but your brain doesn’t recognize that these basic items are critical and important. They were as a child, but as an a adult, now, we can hijack the system to force these activities to be important again.

Graded Motor Imagery

This site seems quite useful to survivors.  These all should be available from your stroke team if they were any good at all. Only $20 Australian. There is a free 5 login trial on Recognise Do not do this on your own, you know how dangerous thinking is post-stroke
Three parts;
1. Left/Right Discrimination
2. Explicit motor imagery
3. Mirror therapy
http://www.gradedmotorimagery.com/index.html

Thursday, December 31, 2015

Benefits of tPA Outweigh Risks in Ischemia Stroke, Even in Patients on Antiplatelet Medications

I wonder about the contraindication of tPA use in the last 3 months? I know I wasn't asked if I was taking aspirin or anything else.
Whom is going to decide if this is enough information to change the stroke protocol on this use? And then disseminate this to all stroke doctors, emergency rooms and stroke hospitals?
WHO IS GOING TO DO THIS?
Our fucking failures of stroke associations obviously will not take on this challenge. You as a stroke patient are simply screwed. YOU will need to remember this and notify your emergency room doctors. 

Benefits of tPA Outweigh Risks in Ischemia Stroke, Even in Patients on Antiplatelet Medications


MedicalResearch.com Interview with:
Ying Xian, PhD

Assistant Professor of Medicine.
Member in the Duke Clinical Research Institute
Medical Research: What is the background for this study? What are the main findings?
Dr. Xian: Intravenous tissue plasminogen activator (tPA) is the only FDA approved medical therapy to reduce disability and improve outcomes for patients with acute ischemic stroke. But treatment with tPA also carries the risk of symptomatic intracranial hemorrhage (sICH), which is often fatal. Nearly half of ischemic stroke patients are taking antiplatelet drugs such as aspirin and/or clopidogrel prior to stroke. We found these patients had higher risk for sICH when treated with tPA. But the risk is relatively small. For every 147 patients on aspirin treated with tPA, only 1 more symptomatic intracranial hemorrhage as compared with those treated with tPA without prior antiplatelet therapy. The risk is slightly higher among those on dual antiplatelet therapy of aspirin and clopidogrel (number needed to harm 60). Despite the higher bleeding risk, patients treated with tPA on prior antiplatelet therapy appeared to have better functional outcomes in terms of ambulatory status and modified Rankin scale than those not on prior antiplatelet therapy. Therefore, overall the benefits of thrombolytic therapy may outweigh the risks.

Medical Research: What should clinicians and patients take away from your report?
Dr. Xian: Considering intravenous tPA is the only FDA approved medical therapy and remains substantially underused worldwide for patients with acute ischemic stroke, clinicians should consider intravenous tPA for eligible patients on prior antiplatelet therapy. I would like to quote from Dr. Mark Alberts, Vice Chair of Clinical Affairs in the Department of Neurology and Neurotherapeutics at UT Southwestern Medical Center, “the real risk is not treating.”
Medical Research: What recommendations do you have for future research as a result of this study?
Dr. Xian: As more potent P2Y12 inhibitors such as prasugrel and ticagrelor are increasingly used in the Unites States, future research is needed provide guidance on tPA for patients who developed ischemic stroke while taking these new antiplatelet drugs.
Citation:

New rehab items from storage locker

Over Christmas I was back in Minnesota and picked up more stuff. Three sleeping bags, enough to allow me to go winter camping again as long as someone I trust can zip me up and out again. My backpack and a couple of Duluth Packs. My camping stove, Svea 123, the greatest stove I've owned. Now all I need is a tent.  My 16 inch gas powered chainsaw, trail clearing here I come. Several friends have said they would do interventions if I attempted to use that. Well I don't even listen to my own voice telling me not to do stuff.

Driving with the affected left arm

Don't assume you can do this if I can. Two years ago I tried this, getting the left hand on the steering wheel at the 11 o'clock position. But failed because my bicep spasticity was stronger than my finger spasticity for grasping. I have to do this in town on stretches of straight road because I have to uncurl my fingers to get them on the wheel. The freeway doesn't work because accelerating down the on ramp at the same time as trying to get the fingers on the wheel doesn't work. My right arm is always available to immediately knock my left arm off the wheel if necessary. This does require the crossover turn signal extender since I never would be able to reach around my left arm to get at the regular turn signal. There is no ability to look over my left shoulder into my blind spot for cars, I'm limited to constantly checking mirrors.  I'm back to 100+% attention to driving again, same as when I started driving.  The tiny corrections needed to keep the car in the lane are great for maybe finally getting some use out of my arm and hand.  I can see in the distant future the ability to drink coffee, change CDs, radio stations and look at passengers when talking to them.

Ten definitions of resilience with respect to the degree of normativity

You will need massive amounts of resilience in order to recover. What is your doctor doing to assist you in that endeavor?
http://www.ecologyandsociety.org/vol12/iss1/art23/table1.html
(I) DESCRIPTIVE CONCEPT
(Ia) ECOLOGICAL SCIENCE
1) Original-ecological Measure of the persistence of systems and of their ability to absorb change and disturbance and still maintain the same relationships between populations or state variables Holling 1973:14



2) Extended-ecological The magnitude of disturbance that can be absorbed before the system changes its structure by changing the variables and processes that control behavior
and
The capacity of a system to experience shocks while retaining essentially the same function, structure, feedbacks, and therefore identity
Gunderson and Holling 2002:4


Walker et al. 2006:2



2a) Three characteristics capacities i) to absorb disturbances, ii) for self-organization, and iii) for learning and adaptation Walker et al. 2002



2b) Four aspects 1) latitude (width of the domain),
2) resistance (height of the domain),
3) precariousness,
4) cross-scale relations
Folke et al. 2004:573



3) Systemic-heuristic Quantitative property that changes throughout ecosystem dynamics and occurs on each level of an ecosystem’s hierarchy Holling 2001



4) Operational Resilience of what to what?
and
The ability of the system to maintain its identity in the face of internal change and external shocks and disturbances
Carpenter et al. 2001
Cumming et al. 2005
(Ib) SOCIAL SCIENCES
5) Sociological The ability of groups or communities to cope with external stresses and disturbances as a result of social, political, and environmental change Adger 2000:347



6) Ecological-economic Transition probability between states as a function of the consumption and production activities of decision makers
and
The ability of the system to withstand either market or environmental shocks without loosing the capacity to allocate resources efficiently
Brock et al. 2002:273


Perrings 2006:418
(II) HYBRID CONCEPT
7) Ecosystem-services-related The underlying capacity of an ecosystem to maintain desired ecosystem services in the face of a fluctuating environment and human use Folke et al. 2002:14



8) Social-ecological system



8a) Social-ecological The capacity of a social-ecological systems to absorb recurrent disturbances (...) so as to retain essential structures, processes and feedbacks Adger et al. 2005:1036



8b) Resilience-approach A perspective or approach to analyze social-ecological systems Folke 2006
(III) NORMATIVE CONCEPT
9) Metaphoric Flexibility over the long term Pickett et al. 2004:381



10) Sustainability-related Maintenance of natural capital in the long run Ott and Döring 2004:213f

3 Hidden Signs that Someone is a Psychopath

I even managed to miss all three signs.
The coffee was a suprising one.
http://www.cheatsheet.com/health-fitness/3-hidden-signs-that-someone-is-a-psychopath.html/?ref=YF

They’re immune to yawning stimuli

They tend to take a lot of selfies - men

They order black coffee

 

Physical Activity Benefits Creativity: Squeezing a Ball for Enhancing Creativity - stroke recovery

You're going to have to become creative with your recovery because your doctor has no clue how to get you 100% recovered. Get your mind out of the gutter, this is serious stuff. Your doctor should be able to tell you which hand used is better for creativity. Your affected one? Or your 'good' one?
http://www.tandfonline.com/doi/abs/10.1080/10400419.2015.1087258
DOI:
10.1080/10400419.2015.1087258
JongHan Kima*
pages 328-333

Abstract

Studies in embodied cognition show that physical sensations, such as touch and movement, influence cognitive processes. Two studies were conducted to test whether squeezing a soft versus a hard ball facilitates different types of creativity. Squeezing a malleable ball would increase divergent creativity by catalyzing multiple or alternative ideas, whereas squeezing a hard ball would increase convergent creativity by facilitating only a single correct response. In Study 1, participants squeezed either a hard ball or a soft ball while completing the Torrance Test of Creative Thinking (TTCT), a divergent creativity test. The same procedures were used in Study 2 except that the TTCT was replaced with the Remote Associates Test, a convergent creativity test. Participants who squeezed a soft ball generated more original and diverse ideas (Study 1), whereas participants who squeezed a hard ball were better at coming up with a single correct answer (Study 2).

Paper Raises More Questions About Salt Restriction In Heart Failure

You'll have to have your doctor weigh in on this. I wonder what this means for blood pressure? It seems that salt restriction is based on appeal to authority.
http://cardiobrief.org/2015/12/28/paper-raises-more-questions-about-salt-restriction-in-heart-failure/

If Health Care Worked Like Amazon - stroke version

Dr. Toni Brayer wrote the original.

If Health Care Worked Like Amazon - stroke version